Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kester

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Microbial Biotechnology|February 24, 2021
Minicell-based fungal RNAi delivery for sustainable crop protectionMd Tabibul Islam, Zachery Davis, Lisa Chen, et al.
Experimental Cell Research|May 22, 2019
Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimenSamy A F Morad, Matthew R MacDougall, Noha Abdelmageed, et al.
Biochemical Pharmacology|February 13, 2017
Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancerSamy A F Morad, Traci S Davis, Matthew R MacDougall, et al.
ACS Nano|February 26, 2010
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivoBrian M Barth, Rahul Sharma, Erhan I Altinoğlu, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
A nano-enhanced vaccine for metastatic melanoma immunotherapyKatelyn E Salotto, Walter C Olson, Karlyn E Pollack, et al.
Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.
Nano Letters|April 16, 2009
Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cellsMark Kester, Yasser Heakal, Todd Fox, et al.
Cancer Letters|May 14, 2013
Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer modelsPavan P Adiseshaiah, Jeffrey D Clogston, Christopher B McLeland, et al.
Journal of Lipid Research|November 12, 2010
Circulating sphingolipid biomarkers in models of type 1 diabetesTodd E Fox, Maria C Bewley, Kellee A Unrath, et al.
Plos One|February 8, 2020
Glucosylceramide synthase maintains influenza virus entry and infectionKelly Drews, Michael P Calgi, William Casey Harrison, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Microbial Biotechnology|February 24, 2021
Minicell-based fungal RNAi delivery for sustainable crop protectionMd Tabibul Islam, Zachery Davis, Lisa Chen, et al.
Experimental Cell Research|May 22, 2019
Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimenSamy A F Morad, Matthew R MacDougall, Noha Abdelmageed, et al.
Biochemical Pharmacology|February 13, 2017
Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancerSamy A F Morad, Traci S Davis, Matthew R MacDougall, et al.
ACS Nano|February 26, 2010
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivoBrian M Barth, Rahul Sharma, Erhan I Altinoğlu, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
A nano-enhanced vaccine for metastatic melanoma immunotherapyKatelyn E Salotto, Walter C Olson, Karlyn E Pollack, et al.
Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.
Nano Letters|April 16, 2009
Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cellsMark Kester, Yasser Heakal, Todd Fox, et al.
Cancer Letters|May 14, 2013
Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer modelsPavan P Adiseshaiah, Jeffrey D Clogston, Christopher B McLeland, et al.
Journal of Lipid Research|November 12, 2010
Circulating sphingolipid biomarkers in models of type 1 diabetesTodd E Fox, Maria C Bewley, Kellee A Unrath, et al.
Plos One|February 8, 2020
Glucosylceramide synthase maintains influenza virus entry and infectionKelly Drews, Michael P Calgi, William Casey Harrison, et al.
Pageof 15